PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-177.89%
Negative net income growth while BTE stands at 923.99%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
15.71%
D&A growth well above BTE's 21.91%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
68.72%
Some yoy growth while BTE is negative at -446.99%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
-8.20%
Negative yoy SBC while BTE is 17.38%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
-163.27%
Both reduce yoy usage, with BTE at -342.95%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-164.71%
AR is negative yoy while BTE is 0.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-78.79%
Both reduce yoy usage, with BTE at -342.95%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-3.45%
Negative yoy while BTE is 23.13%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
3.36%
Operating cash flow growth below 50% of BTE's 23.63%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
-7.61%
Both yoy lines negative, with BTE at -46.10%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-96.47%
Both yoy lines negative, with BTE at -100.00%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
7.61%
Purchases growth of 7.61% while BTE is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-214.29%
We reduce yoy sales while BTE is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-7.61%
Both yoy lines negative, with BTE at -62.57%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-406.71%
Both yoy lines negative, with BTE at -120.76%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.